ARAY
Price
$1.51
Change
+$0.02 (+1.34%)
Updated
May 9 closing price
Capitalization
244.95M
96 days until earnings call
KIDS
Price
$22.04
Change
-$1.04 (-4.51%)
Updated
May 9 closing price
Capitalization
686.7M
81 days until earnings call
Ad is loading...

ARAY vs KIDS

Header iconARAY vs KIDS Comparison
Open Charts ARAY vs KIDSBanner chart's image
Accuray
Price$1.51
Change+$0.02 (+1.34%)
Volume$572.13K
Capitalization244.95M
OrthoPediatrics
Price$22.04
Change-$1.04 (-4.51%)
Volume$130.35K
Capitalization686.7M
ARAY vs KIDS Comparison Chart
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. KIDS commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a StrongBuy and KIDS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (ARAY: $1.51 vs. KIDS: $22.04)
Brand notoriety: ARAY and KIDS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 97% vs. KIDS: 80%
Market capitalization -- ARAY: $244.95M vs. KIDS: $686.7M
ARAY [@Medical Specialties] is valued at $244.95M. KIDS’s [@Medical Specialties] market capitalization is $686.7M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileKIDS’s FA Score has 1 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • KIDS’s FA Score: 1 green, 4 red.
According to our system of comparison, KIDS is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 5 TA indicator(s) are bullish while KIDS’s TA Score has 4 bullish TA indicator(s).

  • ARAY’s TA Score: 5 bullish, 4 bearish.
  • KIDS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than KIDS.

Price Growth

ARAY (@Medical Specialties) experienced а +10.62% price change this week, while KIDS (@Medical Specialties) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

ARAY is expected to report earnings on Aug 14, 2025.

KIDS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KIDS($687M) has a higher market cap than ARAY($245M). KIDS YTD gains are higher at: -4.918 vs. ARAY (-23.737). ARAY has higher annual earnings (EBITDA): 5.93M vs. KIDS (-8.38M). KIDS has more cash in the bank: 80.3M vs. ARAY (72.8M). KIDS has less debt than ARAY: KIDS (10.1M) vs ARAY (202M). ARAY has higher revenues than KIDS: ARAY (447M) vs KIDS (149M).
ARAYKIDSARAY / KIDS
Capitalization245M687M36%
EBITDA5.93M-8.38M-71%
Gain YTD-23.737-4.918483%
P/E RatioN/A232.56-
Revenue447M149M300%
Total Cash72.8M80.3M91%
Total Debt202M10.1M2,000%
FUNDAMENTALS RATINGS
ARAY vs KIDS: Fundamental Ratings
ARAY
KIDS
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9090
PRICE GROWTH RATING
1..100
8559
P/E GROWTH RATING
1..100
405
SEASONALITY SCORE
1..100
3450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARAY's Valuation (84) in the Medical Specialties industry is in the same range as KIDS (91). This means that ARAY’s stock grew similarly to KIDS’s over the last 12 months.

ARAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as KIDS (100). This means that ARAY’s stock grew similarly to KIDS’s over the last 12 months.

ARAY's SMR Rating (90) in the Medical Specialties industry is in the same range as KIDS (90). This means that ARAY’s stock grew similarly to KIDS’s over the last 12 months.

KIDS's Price Growth Rating (59) in the Medical Specialties industry is in the same range as ARAY (85). This means that KIDS’s stock grew similarly to ARAY’s over the last 12 months.

KIDS's P/E Growth Rating (5) in the Medical Specialties industry is somewhat better than the same rating for ARAY (40). This means that KIDS’s stock grew somewhat faster than ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYKIDS
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPGIX38.61N/A
N/A
SEI Large Cap Growth I (SIMT)
GMXIX15.55N/A
N/A
Nationwide Mid Cap Market Idx R6
RYZAX104.89N/A
N/A
Rydex S&P 500 Pure Value H
CLWFX71.20N/A
N/A
Columbia Large Cap Growth Inst2
CSMDX14.68N/A
N/A
Copeland SMID Cap Dividend Growth I

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ALGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+1.34%
ALGN - ARAY
45%
Loosely correlated
+0.53%
PACB - ARAY
42%
Loosely correlated
-6.67%
IQV - ARAY
42%
Loosely correlated
-2.81%
KIDS - ARAY
41%
Loosely correlated
-4.51%
NVST - ARAY
41%
Loosely correlated
-1.01%
More